Ken Song, Founder of Candid Therapeutics

Ken Song is the founder of Candid Therapeutics. Candid Therapeutics has raised $370M, latest Series A $370M (2024). Biotech · San Diego, CA.

About Ken Song

Ken Song is the founder of Candid Therapeutics. Candid Therapeutics operates in Biotech and is based in San Diego, CA. Candid Therapeutics has raised $370M, latest Series A $370M (2024). Backers on record include Jon Flint, Rupert H. Johnson, Steve Arnold, Franklin Templeton, Polaris Partners.

Ken Song at a glance

Company
Candid Therapeutics
Industry
Biotech
Location
San Diego, CA
Total raised
$370M
Investors on record
Jon Flint, Rupert H. Johnson, Steve Arnold, Franklin Templeton, Polaris Partners

Frequently asked about Ken Song

Who is Ken Song?
Ken Song is the founder of Candid Therapeutics. Full profile, funding history and background on StartupFundraising.com.
What company did Ken Song found?
Ken Song founded Candid Therapeutics, a Biotech company based in San Diego, CA.
How do I contact Ken Song?
Verified contact routes including LinkedIn, background and funding history for Ken Song are available on the StartupFundraising.com founder profile.

This founder profile draws on disclosed rounds, filings and investor records in the StartupFundraising database and is updated as new funding is recorded. Founders raising now use profiles like this one to study comparable Biotech journeys in San Diego — who backed them, at what stage, and how much they raised.

More Biotech founders (40)

Browse related founder lists (8)

Full founder directory · Investor directory · Company funding database · Fundraising library